The scientific and ethical feasibility of immunity passports

被引:66
作者
Brown, Rebecca C. H. [1 ]
Kelly, Dominic [2 ,3 ,4 ]
Wilkinson, Dominic [1 ]
Savulescu, Julian [1 ,5 ,6 ]
机构
[1] Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England
[2] Univ Oxford, Dept Paediat, Oxford, England
[3] Oxford Univ Hosp Natl Hlth Serv Fdn Trust, Dept Paediat, Oxford, England
[4] Natl Inst Hlth Res Oxford Biomed Res Ctr, Oxford, England
[5] Murdoch Childrens Res Inst, Biomed Eth Res Grp, Melbourne, Vic, Australia
[6] Univ Melbourne, Melbourne Law Sch, Melbourne, Vic, Australia
基金
英国惠康基金;
关键词
D O I
10.1016/S1473-3099(20)30766-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
There is much debate about the use of immunity passports in the response to the COVID-19 pandemic. Some have argued that immunity passports are unethical and impractical, pointing to uncertainties relating to COVID-19 immunity, issues with testing, perverse incentives, doubtful economic benefits, privacy concerns, and the risk of discriminatory effects. We first review the scientific feasibility of immunity passports. Considerable hurdles remain, but increasing understanding of the neutralising antibody response to COVID-19 might make identifying members of the community at low risk of contracting and transmitting COVID-19 possible. We respond to the ethical arguments against immunity passports and give the positive ethical arguments. First, a strong presumption should be in favour of preserving people's free movement if at all feasible. Second, failing to recognise the reduced infection threat immune individuals pose risks punishing people for low-risk behaviour. Finally, further individual and social benefits are likely to accrue from allowing people to engage in free movement. Challenges relating to the implementation of immunity passports ought to be met with targeted solutions so as to maximise their benefit.
引用
收藏
页码:E58 / E63
页数:6
相关论文
共 62 条
[1]  
Adams Emily R, 2020, Wellcome Open Res, V5, P139, DOI 10.12688/wellcomeopenres.15927.1
[2]   Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate [J].
Addetia, Amin ;
Crawford, Katharine H. D. ;
Dingens, Adam ;
Zhu, Haiying ;
Roychoudhury, Pavitra ;
Huang, Meei-Li ;
Jerome, Keith R. ;
Bloom, Jesse D. ;
Greninger, Alexander L. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (11)
[3]  
Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]
[4]   SARS-CoV-2 Vaccines: Status Report [J].
Amanat, Fatima ;
Krammer, Florian .
IMMUNITY, 2020, 52 (04) :583-589
[5]   Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 [J].
Anderson, Danielle E. ;
Tan, Chee Wah ;
Chia, Wan Ni ;
Young, Barnaby E. ;
Linster, Martin ;
Low, JennyG H. ;
Tan, Yee-Joo ;
Chen, Mark I-C ;
Smith, Gavin J. D. ;
Leo, Yee Sin ;
Lye, David C. ;
Wang, Lin-Fa .
EMERGING MICROBES & INFECTIONS, 2020, 9 (01) :900-902
[6]  
Ball J., 2020, PERVERSE WORLD IMMUN
[7]  
Baylis F, 2020, COVID 19 IMMUNITY TE
[8]  
2020, bioRxiv, DOI [10.1101/2020.07.09.194639, 10.1101/2020.07.09.194639, DOI 10.1101/2020.07.09.194639]
[9]  
Bedingfield W., 2020, WIRED UK
[10]  
British Broadcasting Cooperation, 2020, COR PROF NEIL FERG Q